🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

107 notícias encontradas para "annual"
Uterine aging linked to poorer pregnancy outcomes after 49 despite donor eggs
A major new study suggests that age-related changes in the uterus may contribute to poorer pregnancy outcomes, with women aged 49 and older experiencing lower live birth rates and higher miscarriage risk despite donor-oocyte treatment. Presented at the 42nd Annual Meeting of the
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the 42nd Annual Meeting of the European Society of Human Reproduction and
Foto: Aleksandr Slavich / Pexels
Air pollution may alter how sperm genes function, major fertility study finds
New research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may affect genes associated with sperm development, raising new questions about male fertility, pregnancy outcomes and of
Modern IVF achieves higher success rates with single embryo transfer, major study finds
Modern IVF treatment can now achieve substantially higher success rates than historical approaches while dramatically reducing twin and triplet pregnancies, according to new research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology
Miscarriage and ectopic pregnancy admissions rise in recent years as stark inequalities pe
Hospital admissions for miscarriage and ectopic pregnancy have increased in England in recent years, according to research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). The study abstract was published in Human Reproduc
Nurse practitioner workforce grew 10% yearly, outpacing physicians and PAs from 2016 to 20
New Columbia University School of Nursing research reveals nurse practitioner (NP) workforce growth outpaced prior projections while physician and physician associate (PA) growth remained steady between 2016 and 2023. During this period, the NP workforce expanded at an average an
New clinical data advances stem cell-based cell therapy for Parkinson's disease
New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the
Long-term stroke data reveal stem cell therapy's safety, biological activity over years
Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.
Foto: Negative Space / Pexels
Data highlight progress toward personalized stem cell therapy for Parkinson's disease
Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea
Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now un
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of p
Stem cell strategy for chronic spinal cord injury advances
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting highlights a significant step toward developing a stem cell-based treatment for chronic spinal cord injury (SCI), a condition for which no effective restorative therapy currentl
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells